Stage IV Colon Cancer Survivor Thrives Five Years On
Becky Grubb credits the CU Anschutz Cancer Center's multidisciplinary care and clinical trials - plus a 'huge village' of support - for her quality of life.
New Study Links 'Forever Chemical' to Fetal Facial Abnormalities
Researchers uncover molecular mechanism behind how PFDA, a type of PFAS, disrupts retinoic acid and causes craniofacial defects.
LEO Pharma Presents New 12-Month Real-World Data for Tralokinumab at AAD 2026
Tralokinumab treatment demonstrated improvements in atopic dermatitis severity and quality of life across diverse patient populations.